Tumban is a trained molecular ... generation vaccines against human papillomaviruses (HPVs)—the causative agents of some human cancers (cervical and anogenital cancers). He is exploring strategies to ...

The vaccine, which has been recommended for adolescents since 2006, protects against infection with nine strains of HPV, including high-risk types that are the most likely to cause cervical cancer ...

SEATTLE — Since its approval by the U.S. Food and Drug Administration in 2006, the HPV vaccine has made considerable strides in preventing cervical and oropharyngeal, or throat cancers.